In pancreatic cancers, breakdown of albumin through lysosomal hydrolases has been posited as a major nutrient source [77] and that MTORC1-TFEB signaling is increased specifically by acid-selective accumulation of lysosomotrophic drugs, leading to resistance [78]. The gene discussed is TFEB; the disease is pancreatic neoplasm.